Target intelligence / Profile preview

Pru p 3-specific CD4+ T-cell receptor (Pru p 3-specific TCR)

Target
Pru p 3-specific TCR
Molecular classification
T-cell receptor, Antigen receptor, Heterodimeric protein
01

Overview

Pru p 3-specific CD4+ T-cell receptors are the primary mediators of the cellular immune response to Pru p 3, the major allergen in peach (Prunus persica). These receptors, located on the surface of CD4+ T helper cells, recognize specific peptide fragments of the Pru p 3 protein presented by Major Histocompatibility Complex (MHC) class II molecules. In allergic individuals, the interaction between these TCRs and Pru p 3 epitopes typically triggers a Th2-biased immune response, leading to the production of allergen-specific IgE and subsequent allergic inflammation. Pru p 3 is a non-specific lipid transfer protein (nsLTP) known for its high stability and potential to cause severe systemic reactions, including anaphylaxis. Targeting these TCRs through allergen-specific immunotherapy (AIT) aims to induce immune tolerance by promoting the expansion of regulatory T cells or shifting the cytokine profile toward a Th1-type response. Understanding the specific TCR repertoire and the dominant epitopes, such as Pru p 3 11-25 and 57-71, is crucial for developing safer and more effective peptide-based vaccines for peach allergy.

Other names
Peach allergen Pru p 3-specific TCRnsLTP-specific T-cell receptorPrunus persica allergen 3-specific TCR
02

Mechanism of action

Induction of peripheral T-cell tolerance, anergy, or immune deviation from a Th2-dominated response to a Th1 or regulatory T-cell (Treg) response through repeated exposure to specific Pru p 3 epitopes.

03

Biological functions

Immune responseAntigen recognitionT-cell activationCytokine productionTh2 polarization
04

Disease associations

Peach allergyFood allergyAnaphylaxisPollen-food allergy syndrome
05

Safety considerations

Systemic allergic reactionsAnaphylaxis during immunotherapyCross-reactivity with other non-specific lipid transfer proteins (nsLTPs)
06

Interacting drugs

Pru p 3 allergen extract

3 more in the full profile.

07

Biomarkers

Pru p 3-specific IgEPru p 3-specific IgG4T-cell proliferation indexIL-10 productionCD25+ FoxP3+ regulatory T-cell frequency

Beyond the preview

Go deeper on Pru p 3-specific CD4+ T-cell receptor (Pru p 3-specific TCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pru p 3-specific CD4+ T-cell receptor (Pru p 3-specific TCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call